Synthesis and biological evaluation of novel HIV-1 protease inhibitors using tertiary amine as P2-ligands

被引:20
作者
Yang, Zhi-Heng [1 ,2 ]
Bai, Xiao-Guang [1 ,2 ]
Zhou, Lei [1 ,2 ]
Wang, Ju-Xian [1 ,2 ]
Liu, Hong-Tao [3 ]
Wang, Yu-Cheng [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Inst Med Biotechnol, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
[3] Hebei Gen Hosp, Dept Pharm, Shijiazhuang, Hebei, Peoples R China
基金
中国国家自然科学基金;
关键词
HIV-1; protease; Inhibitors; HAART; Darunavir; STRUCTURE-BASED DESIGN; DRUG-RESISTANCE; INFECTED PATIENTS; THERAPY; MUTATIONS; RITONAVIR; LIGANDS;
D O I
10.1016/j.bmcl.2015.03.047
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of tertiary amine derivatives exhibiting potent HIV-1 protease inhibiting properties were identified. These novel inhibitors were designed based on the structure of Darunavir with modification on the P2 and P2' position. This effort led to discovery of 35e and 38e, which exhibited excellent HIV-1 protease inhibition with IC50 values of 15 nM and 64 nM, respectively. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1880 / 1883
页数:4
相关论文
共 25 条
  • [21] HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
    Shafer, Robert W.
    Rhee, Soo-Yon
    Pillay, Deenan
    Miller, Veronica
    Sandstrom, Paul
    Schapiro, Jonathan M.
    Kuritzkes, Daniel R.
    Bennett, Diane
    [J]. AIDS, 2007, 21 (02) : 215 - 223
  • [22] Joint X-ray/Neutron Crystallographic Study of HIV-1 Protease with Clinical Inhibitor Amprenavir: Insights for Drug Design
    Weber, Irene T.
    Waltman, Mary Jo
    Mustyakimov, Marat
    Blakeley, Matthew P.
    Keen, David A.
    Ghosh, Arun K.
    Langan, Paul
    Kovalevsky, Andrey Y.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (13) : 5631 - 5635
  • [23] Overview of boosted protease inhibitors in treatment-experienced HIV-infected patients
    Youle, Mike
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (06) : 1195 - 1205
  • [24] Selective and facile assay of human immunodeficiency virus protease activity by a novel fluorogenic reaction
    Yu, Zhiqiang
    Kabashima, Tsutomu
    Tang, Chenhong
    Shibata, Takayuki
    Kitazato, Kaio
    Kobayashi, Nobuyuki
    Lee, Myung Koo
    Kai, Masaaki
    [J]. ANALYTICAL BIOCHEMISTRY, 2010, 397 (02) : 197 - 201
  • [25] Pharmacological and therapeutic properties of ritonavir-boosted protease inhibitor therapy in HIV-infected patients
    Zeldin, RK
    Petruschke, RA
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (01) : 4 - 9